Press Releases
Search
-
05 Jul 2005
Hepanostika® HBsAg Ultra – New “ultra”-sensitive test for Hepatitis B infection from bioMérieux
Marcy l’Etoile, France - July 5th, 2005. bioMérieux, a world leader in the field of in vitro diagnostics, announces the launch of its new microelisa assay for the detection of hepatitis B surface anti...
-
23 Jun 2005
Hospices Civils de Lyon and bioMérieux inaugurate a joint immunogenomics and inflammation unit
Lyon, France - June 23, 2005. Hospices Civils de Lyon (HCL) and bioMérieux will inaugurate today the “HCL-bioMérieux” joint unit dedicated to research in immunogenomics and inflammation. The unit is h...
-
07 Jun 2005
NucliSens® easyMAG™ – new innovation from bioMérieux for nucleic acid extraction
Marcy l'Etoile - France - June 7th, 2005. A world leader in the field of in vitro diagnostics, bioMérieux announces the launch of its new automated sample preparation platform for the extraction of nu...
-
25 May 2005
25/05/2005 - MRSA ID - bioMérieux’s latest contribution to the fight against nosocomial infections
Marcy l’Etoile, France - May 25th, 2005. A world leader in the field of in vitro diagnostics, bioMérieux SA announces the launch of a new product for rapid, reliable identification of Methicillin-Resi...
-
23 May 2005
Prospectus about a share buy back program to be submitted at the shareholders' meeting to be held on June 9, 2005
Marcy l'Etoile, France - May 23, 2005.
-
29 Apr 2005
Roche Diagnostics and bioMérieux announce that Roche has granted non exclusive rights for cardiac markers NT-proBNP to bioMérieux
Marcy l’Etoile, France - April 29, 2005. Roche Diagnostics and bioMérieux announced today, that bioMérieux has been granted a nonexclusive license agreement under the patent rights of Roche Diagnostic...